David Kwon, MD | |
9898 Genesee Ave, La Jolla, CA 92037-1205 | |
(858) 824-5404 | |
Not Available |
Full Name | David Kwon |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 10 Years |
Location | 9898 Genesee Ave, La Jolla, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922425297 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Kaiser Foundation Hospital - Downey | Downey, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies Ltd., a Bangalore based fully integrated, global biotech focused on small molecule and peptide drug discovery and development from target identification and validation to pre IND drug candidates, today announced the successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway.
"Urban America continues to suffer high rates of HIV despite successes of antiretroviral treatment that can suppress the virus, decrease transmission, prevent progression to AIDS, and lower death rates," Gregory Pappas, senior deputy director of the Washington, D.C., Department of Health's HIV/AIDS, Hepatitis, STD and TB Administration (HAHSTA), writes in a Washington Blade opinion piece.
As countries around the world roll out H1N1 (swine flu) virus vaccine campaigns, the Atlantic examines, "[W]hat if everything we think we know about fighting influenza is wrong?"
A protein whose primary role is in the embryonic development of kidneys may play a future role in treating kidney failure. Indiana University School of Medicine researchers have successfully treated acute kidney injury in laboratory experiments using cells that were genetically reprogrammed to produce the protein. The research suggests there could be a potential future treatment using such cells delivered intravenously instead of surgically.
› Verified 4 days ago
Entity Name | Southern California Permanente Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies Ltd., a Bangalore based fully integrated, global biotech focused on small molecule and peptide drug discovery and development from target identification and validation to pre IND drug candidates, today announced the successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway.
"Urban America continues to suffer high rates of HIV despite successes of antiretroviral treatment that can suppress the virus, decrease transmission, prevent progression to AIDS, and lower death rates," Gregory Pappas, senior deputy director of the Washington, D.C., Department of Health's HIV/AIDS, Hepatitis, STD and TB Administration (HAHSTA), writes in a Washington Blade opinion piece.
As countries around the world roll out H1N1 (swine flu) virus vaccine campaigns, the Atlantic examines, "[W]hat if everything we think we know about fighting influenza is wrong?"
A protein whose primary role is in the embryonic development of kidneys may play a future role in treating kidney failure. Indiana University School of Medicine researchers have successfully treated acute kidney injury in laboratory experiments using cells that were genetically reprogrammed to produce the protein. The research suggests there could be a potential future treatment using such cells delivered intravenously instead of surgically.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
David Kwon, MD 10790 Rancho Bernardo Rd, San Diego, CA 92127-5705 Ph: (858) 824-5404 | David Kwon, MD 9898 Genesee Ave, La Jolla, CA 92037-1205 Ph: (858) 824-5404 |
News Archive
Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies Ltd., a Bangalore based fully integrated, global biotech focused on small molecule and peptide drug discovery and development from target identification and validation to pre IND drug candidates, today announced the successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway.
"Urban America continues to suffer high rates of HIV despite successes of antiretroviral treatment that can suppress the virus, decrease transmission, prevent progression to AIDS, and lower death rates," Gregory Pappas, senior deputy director of the Washington, D.C., Department of Health's HIV/AIDS, Hepatitis, STD and TB Administration (HAHSTA), writes in a Washington Blade opinion piece.
As countries around the world roll out H1N1 (swine flu) virus vaccine campaigns, the Atlantic examines, "[W]hat if everything we think we know about fighting influenza is wrong?"
A protein whose primary role is in the embryonic development of kidneys may play a future role in treating kidney failure. Indiana University School of Medicine researchers have successfully treated acute kidney injury in laboratory experiments using cells that were genetically reprogrammed to produce the protein. The research suggests there could be a potential future treatment using such cells delivered intravenously instead of surgically.
› Verified 4 days ago
Dr. John Sturdivant Andrews, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1223 Via Barranca, La Jolla, CA 92037 Phone: 858-775-1976 | |
Dr. Mark C Adrian, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 9850 Genesee Ave, Suite 355, La Jolla, CA 92037 Phone: 858-202-0011 | |
Dr. Erminia M. Guarneri, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-3330 Fax: 858-784-5933 | |
Dr. Eric Hong, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 9834 Genesee Ave, Suite 300, La Jolla, CA 92037 Phone: 858-824-2900 Fax: 858-824-2910 | |
Katrina Deleon, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-6158 | |
Abhishek Gadre, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 9300 Campus Point Dr, La Jolla, CA 92037 Phone: 858-657-7118 | |
Kamran Hussain Imam, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-6158 |